Teva Pharmaceuticals USA is recalling approximately 1,609,962 bottles of Cephalexin for Oral Suspension (an antibiotic) because some bottles may contain too much or too little of the active ingredient. The recall includes 125 mg and 250 mg strengths sold in 100 mL and 200 mL bottles nationwide across the U.S. and Puerto Rico. This defect was discovered through testing that showed some batches fell below the required potency levels, which can impact the effectiveness of the treatment. Consumers should contact their healthcare provider to discuss their treatment and obtain a replacement if they have an affected bottle.
If a medication is sub-potent (too weak), it may fail to treat the underlying infection effectively, potentially leading to more serious illness or antibiotic resistance. Conversely, if a medication is over-potent (too strong), it could increase the risk of side effects or adverse reactions.
Healthcare guidance and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.